Sarnak M J, Long J, King A J
Division of Nephrology, New England Medical Center, Boston, Massachusetts 02111, USA.
Clin Nephrol. 1999 Feb;51(2):122-5.
Intravesicular formaldehyde has been used for intractable hemorrhagic cystitis since the late 1960's. Initial reports described few complications, but in the 1970's both ureteral as well renal parenchymal damage were reported in the urology literature. This has been less appreciated by nephrologists perhaps related to the paucity of reports in the nephrology literature. Although the pathogenesis has not been rigorously studied ureteral toxicity may be secondary to intense edema, inflammation and subsequent fibrosis induced by the formaldehyde; while renal tubular injury may be secondary to systemic absorption of formaldehyde. Ureteral reflux as well as dosage of intravesicular formaldehyde seem to be risk factors for acute renal failure. We describe a case of acute renal failure secondary to intravesicular formaldehyde and review pathogenesis as well as potential prophylactic measures to prevent this complication.
自20世纪60年代末以来,膀胱内注入甲醛一直用于治疗难治性出血性膀胱炎。最初的报告描述的并发症很少,但在20世纪70年代,泌尿外科文献中报道了输尿管以及肾实质损伤。肾病学家对此了解较少,这可能与肾病学文献中报道较少有关。虽然发病机制尚未得到严格研究,但输尿管毒性可能继发于甲醛引起的强烈水肿、炎症及随后的纤维化;而肾小管损伤可能继发于甲醛的全身吸收。输尿管反流以及膀胱内甲醛的剂量似乎是急性肾衰竭的危险因素。我们描述了一例继发于膀胱内注入甲醛的急性肾衰竭病例,并回顾了其发病机制以及预防该并发症的潜在预防措施。